Get started
BLISS GVS PHARMA LTDBLISS GVS PHARMA LTDBLISS GVS PHARMA LTD

BLISS GVS PHARMA LTD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

BLISSGVS chart


Full chart

BLISSGVS upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪16.84 B‬ INR
Dividend yield (indicated)
0.31%
Price to earnings Ratio (TTM)
26.70
Basic EPS (TTM)
6.05 INR
Net income (FY)
‪754.54 M‬ INR
Revenue (FY)
‪7.66 B‬ INR
Shares float
‪36.66 M‬
Beta (1Y)
1.96

Employees


Employees (FY)
831
Change (1Y)
+68 +8.91%
Revenue / Employee (1Y)
‪9.22 M‬ INR
Net income / Employee (1Y)
‪907.99 K‬ INR

About BLISS GVS PHARMA LTD


Sector
Health Technology
CEO
Gagan Harsh Sharma
Headquarters
Mumbai
Website
blissgvs.com
Founded
1984
ISIN
INE416D01022
FIGI
BBG000BHSFQ7
Bliss GVS Pharma Ltd. engages in the development, manufacture, and marketing of pharmaceutical formulations. Its products include capsules; creams, gels, and ointment; dry powder for injection and oral suspension; effervescent tablets; eye and ear drops; injection; liquid preparations; lotions; lozenges; nasal solution; oral solids; parenteral; pessaries; sachets; soft gelatin capsules; suppositories; suspension; syrups; tablets; and topical preparations. The company was founded on December 11, 1984 and is headquartered in Mumbai, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BLISSGVS news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BLISSGVS is 159.92 INR — it has increased by 0.72% in the past 24 hours. Watch BLISS GVS PHARMA LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange BLISS GVS PHARMA LTD stocks are traded under the ticker BLISSGVS.
BLISSGVS stock has fallen by −9.19% compared to the previous week, the month change is a 24.07% rise, over the last year BLISS GVS PHARMA LTD has showed a 28.14% increase.
BLISSGVS reached its all-time high on Dec 30, 2020 with the price of 221.00 INR, and its all-time low was 18.80 INR and was reached on Oct 3, 2011. View more price dynamics on BLISSGVS chart.
See other stocks reaching their highest and lowest prices.
BLISSGVS stock is 2.46% volatile and has beta coefficient of 1.96. Track BLISS GVS PHARMA LTD stock price on the chart and check out the list of the most volatile stocks — is BLISS GVS PHARMA LTD there?
Today BLISS GVS PHARMA LTD has the market capitalization of ‪16.84 B‬, it has decreased by −5.36% over the last week.
Yes, you can track BLISS GVS PHARMA LTD financials in yearly and quarterly reports right on TradingView.
BLISS GVS PHARMA LTD is going to release the next earnings report on Jan 28, 2025. Keep track of upcoming events with our Earnings Calendar.
BLISSGVS net income for the last quarter is ‪242.60 M‬ INR, while the quarter before that showed ‪206.97 M‬ INR of net income which accounts for 17.21% change. Track more BLISS GVS PHARMA LTD financial stats to get the full picture.
Yes, BLISSGVS dividends are paid annually. The last dividend per share was 0.50 INR. As of today, Dividend Yield (TTM)% is 0.31%. Tracking BLISS GVS PHARMA LTD dividends might help you take more informed decisions.
BLISS GVS PHARMA LTD dividend yield was 0.44% in 2023, and payout ratio reached 6.91%. The year before the numbers were 0.70% and 7.32% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has 831.00 employees. See our rating of the largest employees — is BLISS GVS PHARMA LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BLISS GVS PHARMA LTD EBITDA is ‪1.48 B‬ INR, and current EBITDA margin is 19.52%. See more stats in BLISS GVS PHARMA LTD financial statements.
Like other stocks, BLISSGVS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BLISS GVS PHARMA LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BLISS GVS PHARMA LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BLISS GVS PHARMA LTD stock shows the buy signal. See more of BLISS GVS PHARMA LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.